Concepedia

Vladimír Vdovin

VV

6

Publications

229

Citations

6

H-Index

2013

Active since

Affiliations

Medical University of Warsaw(Current)

Octapharma (Switzerland)

Octapharma (Austria)

Russian Children's Clinical Hospital

University College London

Vladimír Vdovin is an author at Medical University of Warsaw specializing in allergy, immunology, and immunohematology.

ORCID

Top concepts

Publications per year

2013–2021

6

Publications

6

Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia <scp>A</scp>: safety, efficacy and pharmacokinetics

Roshni Kulkarni, F. Abdul Karim, S. Glamocanin et al. · Haemophilia · 2013 · 61 citations

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

W. Kreuz, Carmen Escuriola Ettingshausen, Vladimír Vdovin et al. · Haemophilia · 2015 · 56 citations · Full text

Novel, human cell line‐derived recombinant factor <scp>VIII</scp> (Human‐cl rh<scp>FVIII</scp>, Nuwiq<sup>®</sup>) in children with severe haemophilia A: efficacy, safety and pharmacokinetics

Anna Klukowska, Tomasz Szczepański, Vladimír Vdovin et al. · Haemophilia · 2015 · 44 citations · Full text

Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human‐cl rh<scp>FVIII</scp>) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study

Ri Liesner, Marina Abashidze, Olga Aleinikova et al. · Haemophilia · 2017 · 27 citations · Full text

Simoctocog Alfa (Nuwiq) in Previously Untreated Patients with Severe Haemophilia A: Final Results of the NuProtect Study

Ri Liesner, Aby Abraham, Carmen Altisent et al. · Thrombosis and Haemostasis · 2021 · 27 citations · Full text

, , +17

Rows per page

1–5 of 6